China Biologic Products Inc news

   Watch this stock
Showing stories 1 - 10 of about 83   

Articles published

CBPO 105.87 +0.35 (0.33%)
price chart
Price Forecast For China Biologic Products, Inc. (NASDAQ:CBPO)
Analysts on Wall Street have announced an immediate price target of $161.5 on shares of China Biologic Products, Inc. (NASDAQ:CBPO). This is as per the 2 experts polled by Zacks. The brokerage entity with the most bullish expectation has a $185 target.
Is Selling Stock Like China Biologic Products Inc After Such Decline Winning ...  Sonoran Weekly Review
China Biologic Products Inc (CBPO) Shares Bought by CIBC Asset Management Inc  Daily Political
China Biologic Products (CBPO) Highlighted as Today's Perilous Reversal Stock
China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China.
Stock On Radar - China Biologic Products, Inc. (NASDAQ:CBPO)  Vanguard Tribune
China Biologic Products, Inc. (NASDAQ:CBPO) Stock Target and Ratings Update  SmallCapWired.com
Brokerages Anticipate China Biologic Products Inc (NASDAQ:CBPO) to Announce $0 ...
China Biologic Products logo China Biologic Products Inc (NASDAQ:CBPO) has received a consensus broker rating score of 1.00 (Strong Buy) from the three analysts that cover the company, Zacks Investment Research reports.
Momentum Rating China Biologic Products, Inc. (NASDAQ:CBPO)  Enterprise Leader
5 Stocks Under Wall Street's Radar: Allegiant Travel Company (NASDAQ ...  Stock Transcript
Shining on Major News: China Biologic Products, Inc. (NASDAQ:CBPO), Huntington ...
China Biologic Products Inc (NASDAQ:CBPO) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday, Marketbeat.
China Biologic Products, Inc. (NASDAQ:CBPO) Recent Analyst Updates
A number of investment brokers have recently updated their price targets on shares of China Biologic Products, Inc. (NASDAQ:CBPO).
China Biologic Products Inc (CBPO) Stock Rating Lowered by Zacks Investment ...
China Biologic Products logo China Biologic Products Inc (NASDAQ:CBPO) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday, Marketbeat.
China Biologic Products Inc (CBPO) Stock Price Up 2.6% on Analyst Upgrade  Zolmax
Company Shares of China Biologic Products, Inc. (NASDAQ:CBPO) Rally 2.85%
Shares of China Biologic Products, Inc. (NASDAQ:CBPO) appreciated by 2.85% during the past week but lost 9.96% on a 4-week basis.
China Biologic Products, Inc. (NASDAQ:CBPO): Stock in the spotlight
Sell-side analysts maintain a positive outlook on the shares of China Biologic Products, Inc. (NASDAQ:CBPO). Based on the poll results published by the Zacks Research, the stock of the company has been assigned a 1 rating.
China Biologic Products Inc (CBPO) Shares Gap Up After Analyst Upgrade
China Biologic Products logo China Biologic Products Inc (NASDAQ:CBPO)'s share price gapped up prior to trading on Friday after Deutsche Bank raised their price target on the stock from $149.00 to $162.00, MarketBeat reports.
China Biologic Products Inc - Get News & Ratings Daily  Corvus Business Newswire
China Biologic Products Inc (CBPO) Price Target Raised to $162.00 at ...  Zolmax
Market View On China Biologic Products, Inc. (NASDAQ:CBPO)
Few brokerages covering China Biologic Products, Inc. (NASDAQ:CBPO) have recently released its earnings and stock price target.